These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 8769688)

  • 21. Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor.
    Aviezer D; Levy E; Safran M; Svahn C; Buddecke E; Schmidt A; David G; Vlodavsky I; Yayon A
    J Biol Chem; 1994 Jan; 269(1):114-21. PubMed ID: 8276782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possible mechanism for lead inhibition of vascular endothelial cell proliferation: a lower response to basic fibroblast growth factor through inhibition of heparan sulfate synthesis.
    Fujiwara Y; Kaji T
    Toxicology; 1999 Apr; 133(2-3):147-57. PubMed ID: 10378481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Basic fibroblast growth factor production and growth factor receptors as potential targets for melanoma therapy.
    Kato J; Wanebo H; Calabresi P; Clark JW
    Melanoma Res; 1992 May; 2(1):13-23. PubMed ID: 1322754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of the association of IGF-I, IGF-II, bFGF, TGF-beta1, GM-CSF, and LIF on the development of bovine embryos produced in vitro.
    Neira JA; Tainturier D; Peña MA; Martal J
    Theriogenology; 2010 Mar; 73(5):595-604. PubMed ID: 20035987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet factor 4 modulates the mitogenic activity of basic fibroblast growth factor.
    Watson JB; Getzler SB; Mosher DF
    J Clin Invest; 1994 Jul; 94(1):261-8. PubMed ID: 8040268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transforming growth factor-beta 1 increases internalization of basic fibroblast growth factor by smooth muscle cells: implication of cell-surface heparan sulphate proteoglycan endocytosis.
    Berrou E; Quarck R; Fontenay-Roupie M; Lévy-Toledano S; Tobelem G; Bryckaert M
    Biochem J; 1995 Oct; 311 ( Pt 2)(Pt 2):393-9. PubMed ID: 7487873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteoheparan sulfates contribute to the binding of basic FGF to its high affinity receptors on bovine adrenocortical cells.
    Savona C; Chambaz EM; Feige JJ
    Growth Factors; 1991; 5(4):273-82. PubMed ID: 1663773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen effects on insulin-like growth factor-I (IGF-I)-induced cell proliferation and IGF-I expression in native and allograft vessels.
    Lou H; Zhao Y; Delafontaine P; Kodama T; Katz N; Ramwell PW; Foegh ML
    Circulation; 1997 Aug; 96(3):927-33. PubMed ID: 9264503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Basic fibroblast growth factor inhibits the anabolic activity of insulin-like growth factor 1 and osteogenic protein 1 in adult human articular chondrocytes.
    Loeser RF; Chubinskaya S; Pacione C; Im HJ
    Arthritis Rheum; 2005 Dec; 52(12):3910-7. PubMed ID: 16320338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular cell-derived heparan sulfate shows coupled inhibition of basic fibroblast growth factor binding and mitogenesis in vascular smooth muscle cells.
    Nugent MA; Karnovsky MJ; Edelman ER
    Circ Res; 1993 Dec; 73(6):1051-60. PubMed ID: 8222077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparan sulfate proteoglycans control intracellular processing of bFGF in vascular smooth muscle cells.
    Sperinde GV; Nugent MA
    Biochemistry; 1998 Sep; 37(38):13153-64. PubMed ID: 9748322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin-like growth factors maintain steady-state metabolism of proteoglycans in bovine articular cartilage explants.
    Luyten FP; Hascall VC; Nissley SP; Morales TI; Reddi AH
    Arch Biochem Biophys; 1988 Dec; 267(2):416-25. PubMed ID: 3214163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PKC delta-induced activation of MAPK pathway is required for bFGF-stimulated proliferation of coronary smooth muscle cells.
    Skaletz-Rorowski A; Eschert H; Leng J; Stallmeyer B; Sindermann JR; Pulawski E; Breithardt G
    Cardiovasc Res; 2005 Jul; 67(1):142-50. PubMed ID: 15949478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitogenic activity of epidermal growth factor on newborn rat astroglia: interaction with insulin-like growth factors.
    Han VK; Smith A; Myint W; Nygard K; Bradshaw S
    Endocrinology; 1992 Sep; 131(3):1134-42. PubMed ID: 1380434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitory effects of basic fibroblast growth factor on chondrocyte differentiation.
    Wroblewski J; Edwall-Arvidsson C
    J Bone Miner Res; 1995 May; 10(5):735-42. PubMed ID: 7639109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous basic fibroblast growth factor displaced by heparin from the lumenal surface of human blood vessels is preferentially sequestered by injured regions of the vessel wall.
    Medalion B; Merin G; Aingorn H; Miao HQ; Nagler A; Elami A; Ishai-Michaeli R; Vlodavsky I
    Circulation; 1997 Apr; 95(7):1853-62. PubMed ID: 9107173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture.
    Imai Y; Busby WH; Smith CE; Clarke JB; Garmong AJ; Horwitz GD; Rees C; Clemmons DR
    J Clin Invest; 1997 Nov; 100(10):2596-605. PubMed ID: 9366575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bovine arterial smooth muscle cells synthesize two functionally different proteoheparan sulfate species.
    Schmidt A; Buddecke E
    Exp Cell Res; 1990 Aug; 189(2):269-75. PubMed ID: 2142464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Release of cell surface-associated basic fibroblast growth factor by glycosylphosphatidylinositol-specific phospholipase C.
    Bashkin P; Neufeld G; Gitay-Goren H; Vlodavsky I
    J Cell Physiol; 1992 Apr; 151(1):126-37. PubMed ID: 1313817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contribution of insulin-like growth factor (IGF)-I and IGF-binding protein-3 to mitogenic activity in bovine mammary extracts and serum.
    Weber MS; Purup S; Vestergaard M; Ellis SE; Scndergård-Andersen J; Akers RM; Sejrsen K
    J Endocrinol; 1999 Jun; 161(3):365-73. PubMed ID: 10333539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.